Short answer · Medically reviewed summary · Last updated: 2023-07-13
Ornithine Transcarbamylase Deficiency (OTC deficiency) is a rare genetic disorder that affects the urea cycle, a process that helps remove ammonia from the body. This condition is caused by a mutation in the OTC gene, which is located on the X chromosome.
Is Ornithine Transcarbamylase Deficiency hereditary?
Is Ornithine Transcarbamylase Deficiency hereditary? The genetic component explained in plain language, reviewed against medical sources, with patient experiences.
Ornithine Transcarbamylase Deficiency (OTC deficiency) is a rare genetic disorder that affects the urea cycle, a process that helps remove ammonia from the body. This condition is caused by a mutation in the OTC gene, which is located on the X chromosome. As a result, OTC deficiency is an X-linked recessive disorder.
Being an X-linked disorder means that the gene responsible for OTC deficiency is located on the X chromosome. Females have two X chromosomes (XX), while males have one X and one Y chromosome (XY). Since the OTC gene is located on the X chromosome, males are more commonly affected by this disorder than females.
If a female carries a single copy of the mutated OTC gene, she is considered a carrier and typically does not show symptoms of the disorder. However, she has a 50% chance of passing the mutated gene to each of her children. If a male inherits the mutated gene, he will develop OTC deficiency.
It is important to note that not all individuals with OTC deficiency have a family history of the disorder. In some cases, the mutation occurs spontaneously during the formation of reproductive cells or early embryonic development.
Genetic counseling and testing can help determine the risk of OTC deficiency in families with a history of the disorder. Prenatal testing is also available for families who wish to assess the risk of OTC deficiency in their unborn child.
